Figures computed from official regulatory filings — methodology.
| Insider | Type | Value · USD | |
|---|---|---|---|
| DRACHMAN JONATHAN G | Award | $0 | SEC |
| Chin Mark | OtherD | — | SEC |
| Chin Mark | OtherD | — | SEC |
| HUNT RONALD | OtherD | — | SEC |
| Lanza Frank J | OtherD | — | SEC |
| DRACHMAN JONATHAN G | OtherD | — | SEC |
| New Leaf Venture Associates III, L.P. | OtherD | — | SEC |
| Robbins Andrew R | Other | — | SEC |
| Robbins Andrew R | OtherD | — | SEC |
| BAILES JOSEPH S | OtherD | — | SEC |
| Walker Luke Nathaniel | OtherD | — | SEC |
| Merck & Co., Inc. | Buy | $492.1M | SEC |
| New Leaf Venture Associates III, L.P. | Other | — | SEC |
| SILVERNAIL LAUREN P | OtherD | — | SEC |
| BAILES JOSEPH S | Other | — | SEC |
| EASTLAND JULIA MARIE | OtherD | — | SEC |
| Myers Scott Dunseth | OtherD | — | SEC |
| Chin Mark | Other | — | SEC |
| Walker Luke Nathaniel | Other | — | SEC |
| HUNT RONALD | OtherD | — | SEC |
| SILVERNAIL LAUREN P | Other | — | SEC |
| HUNT RONALD | Other | — | SEC |
| Myers Scott Dunseth | OtherD | — | SEC |
| EASTLAND JULIA MARIE | Other | — | SEC |
| Lanza Frank J | OtherD | — | SEC |